B Nkrumah1, M Owusu, H O Frempong, P Averu. 1. Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana. nkrumah@kccr.de
Abstract
OBJECTIVE: To investigate the prevalence of Hepatitis B and C infections and co-infections among blood donors in a rural community of Ghana. DESIGN: A retrospective study. METHOD: Samples of blood donated between January 2007 and December 2008 were screen for Hepatitis B and C viruses at the Agogo Presbyterian Hospital. RESULTS: The prevalence of Hepatitis B viral (HBV) infection was highest in females 21.4% (95% CI: 11.6-34.4) in 2006 than males in the same year 13.2% (95% CI: 10.8-15.9). Hepatitis C viral (HCV) infection was highest among males at 11.6% (95% CI: 9.5-13.8) in 2007. HBV and HCV co-infection was higher in males 2.6% (95% CI: 1.6-3.8) than females 1.3% (95% CI: 0-7.0) in 2007. The overall prevalence of HBV and HCV was 13.8% (95% CI: 11.4-16.4) and 9.4% (95% CI: 7.4-11.6) respectively in 2006. The rate of co-infection of HBV and HCV however increased from 1.6% (95% CI: 0.8-2.7) in 2006 to 2.2% (95% CI: 1.3-3.2) in 2008 in males and from 0% (95% CI: 0-6.4) in 2006 to 1.2% (95% CI: 0-6.5) in 2008 in females. CONCLUSION: The single infections of HBV and HCV reduced but co-infection of these transfusion transmitted infections (TTI) increased. Measures such as more sensitive techniques and education must be employed in these areas.
OBJECTIVE: To investigate the prevalence of Hepatitis B and C infections and co-infections among blood donors in a rural community of Ghana. DESIGN: A retrospective study. METHOD: Samples of blood donated between January 2007 and December 2008 were screen for Hepatitis B and C viruses at the Agogo Presbyterian Hospital. RESULTS: The prevalence of Hepatitis B viral (HBV) infection was highest in females 21.4% (95% CI: 11.6-34.4) in 2006 than males in the same year 13.2% (95% CI: 10.8-15.9). Hepatitis C viral (HCV) infection was highest among males at 11.6% (95% CI: 9.5-13.8) in 2007. HBV and HCV co-infection was higher in males 2.6% (95% CI: 1.6-3.8) than females 1.3% (95% CI: 0-7.0) in 2007. The overall prevalence of HBV and HCV was 13.8% (95% CI: 11.4-16.4) and 9.4% (95% CI: 7.4-11.6) respectively in 2006. The rate of co-infection of HBV and HCV however increased from 1.6% (95% CI: 0.8-2.7) in 2006 to 2.2% (95% CI: 1.3-3.2) in 2008 in males and from 0% (95% CI: 0-6.4) in 2006 to 1.2% (95% CI: 0-6.5) in 2008 in females. CONCLUSION: The single infections of HBV and HCV reduced but co-infection of these transfusion transmitted infections (TTI) increased. Measures such as more sensitive techniques and education must be employed in these areas.
Authors: Steven H Kleinman; Mary C Kuhns; Deborah S Todd; Simone A Glynn; Anne McNamara; Anthony DiMarco; Michael P Busch Journal: Transfusion Date: 2003-06 Impact factor: 3.157
Authors: D Jeannel; C Fretz; Y Traore; N Kohdjo; A Bigot; E Pê Gamy; G Jourdan; K Kourouma; G Maertens; F Fumoux; J J Fournel; L Stuyver Journal: J Med Virol Date: 1998-06 Impact factor: 2.327
Authors: David K Dosoo; Kwaku P Asante; Kingsley Kayan; Dennis Adu-Gyasi; Kingsley Osei-Kwakye; Emmanuel Mahama; Samuel Danso; Stephen Amenga-Etego; Philip Bilson; Kwadwo A Koram; Seth Owusu-Agyei Journal: Am J Trop Med Hyg Date: 2014-03-03 Impact factor: 2.345
Authors: David K Dosoo; Kingsley Kayan; Dennis Adu-Gyasi; Evans Kwara; Josephine Ocran; Kingsley Osei-Kwakye; Emmanuel Mahama; Stephen Amenga-Etego; Philip Bilson; Kwaku P Asante; Kwadwo A Koram; Seth Owusu-Agyei Journal: PLoS One Date: 2012-04-27 Impact factor: 3.240
Authors: Joseph C Forbi; Jennifer E Layden; Richard O Phillips; Nallely Mora; Guo-Liang Xia; David S Campo; Michael A Purdy; Zoya E Dimitrova; Dorcas O Owusu; Lili T Punkova; Pavel Skums; Shirley Owusu-Ofori; Fred Stephen Sarfo; Gilberto Vaughan; Hajung Roh; Ohene K Opare-Sem; Richard S Cooper; Yury E Khudyakov Journal: PLoS One Date: 2015-12-18 Impact factor: 3.240
Authors: Joseph C Forbi; David S Campo; Michael A Purdy; Zoya E Dimitrova; Pavel Skums; Guo-liang Xia; Lili T Punkova; Lilia M Ganova-Raeva; Gilberto Vaughan; Yousr Ben-Ayed; William M Switzer; Yury E Khudyakov Journal: J Med Virol Date: 2014-02-12 Impact factor: 2.327